InMode Ltd. (INMD)

NASDAQ: INMD · USD

$13.4

-0.21 (-1.6%)· Recorded snapshot

Market cap	768.2M
Revenue (ttm)	374.6M
Net income (ttm)	77.5M
EPS (ttm)	$1.22
Shares out	57.5M
P/E (trailing)	11.0x
P/E (forward)	10.1x
Volume	452,550
Beta	2.03

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 374.6M
Net income (ttm): 77.5M
EPS (ttm): $1.22
P/E (trailing): 11.0x
P/E (forward): 10.1x
Market cap: 768.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E10.1

P25 13.4P50 20.2P75 35.7

Trailing P/E11

P25 15.4P50 25.8P75 43.5

ROE12.3

P25 -113.8P50 -46.5P75 -0.9

ROIC45.9

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All INMD indicators

Market & fundamental data

Available fields

260

Groups with data

Currency

USD

Showing 260 of 260 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001742692
Company name	InMode Ltd.
Country	Israel
Country code	US
CUSIP number	M5425M103
Earnings date	2026-11-11
Earnings time	bmo
Employees	660
Employees change	61
Employees growth	10.18%
Enterprise value	$271.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2008
Industry	Medical Devices
IPO date	2019-08-08
Is primary listing	Yes
Is SPAC	No
ISIN number	IL0011595993
Last 10-K release date	2026-02-10
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split date	2021-10-01
Last stock split type	Forward
Market cap	$768.2M
Market cap category	Small-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$13.37
Price currency	USD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	INMD
Website	https://www.inmodemd.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	9.28x
Average P/E ratio (10Y)	16.06x
Average P/E ratio (3Y)	9.17x
Average P/E ratio (5Y)	13.86x
Earnings yield	9.11%
EV/Earnings	3.51x
EV/EBIT	3.86x
EV/EBITDA	3.82x
EV/FCF	3.29x
EV/Sales	0.73x
FCF / EV yield	30.36%
FCF yield	10.74%
Forward EV/Sales	0.74x
Forward P/E	10.11x
Forward P/S	2.08x
Graham number	17.10361
Graham upside	27.93%
Industry forward P/E	19.81x
Industry P/E	39.28x
Lynch fair value	$6.09
Lynch upside	-54.48%
P/(FCF - SBC) ratio	10.84x
P/(OCF - SBC) ratio	10.68x
P/B ratio	1.27x
P/E ratio	10.98x
P/FCF ratio	9.31x
P/OCF ratio	9.2x
P/S ratio	2.05x
Price / tangible book value	1.22x
Price/EBITDA ratio	10.8x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	18.81%
EBITDA margin	18.99%
Effective tax rate	14.77%
FCF margin	22.03%
Gross margin	76.52%
Operating margin	18.81%
Pretax margin	24.28%
Profit margin	20.69%
Profit per employee	$117,445
Profitable quarters	30
Profitable years	9
Revenue per employee	$567,614
ROA	6.17%
ROA (5Y)	16.14%
ROCE	10.99%
ROE	12.33%
ROE (5Y)	29.96%
ROIC	45.95%
ROIC (5Y)	11,817.11%
SBC / revenue	3.1%
Tax / revenue	3.59%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-51.99%
EPS growth (Q)	-31.03%
EPS growth (QoQ)	60.94%
EPS growth 3Y	-17.01%
EPS growth 5Y	-4.03%
EPS growth years	0
FCF growth	-20.64%
FCF growth (Q)	-12.63%
FCF growth (QoQ)	36.98%
FCF growth 3Y	-22.25%
FCF growth 5Y	-10.37%
Gross profit growth	-10.74%
Gross profit growth (Q)	-6.45%
Gross profit growth 3Y	-11.73%
Gross profit growth 5Y	3.19%
Net income growth	-56.62%
Net income growth (Q)	-36.19%
Net income growth (QoQ)	47.59%
Net income growth 3Y	-24.86%
Net income growth 5Y	-9.48%
Net income growth years	0
OCF growth	-20.1%
OCF growth (Q)	-12.55%
OCF growth (QoQ)	36.82%
OCF growth 3Y	-22.11%
OCF growth 5Y	-10.22%
Operating income growth	-38.53%
Operating income growth (Q)	-46.43%
Operating income growth 3Y	-30.69%
Operating income growth 5Y	-11.12%
Revenue growth	-6.71%
Revenue growth (Q)	-0.01%
Revenue growth (QoQ)	16.55%
Revenue growth 3Y	-8.99%
Revenue growth 5Y	5.42%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.1M
Depreciation and amortization	$684,000
EBIT	$70.5M
EBITDA	$71.1M
EPS	$1.22
FCF per share	$1.44
Financing cash flow	$-88.5M
Free cash flow	$82.5M
Free cash flow minus SBC	$70.9M
Gross profit	$286.7M
Income taxes	$13.4M
Investing cash flow	$185.7M
Net cash flow	$179.9M
Net income	$77.5M
Operating cash flow minus SBC	$72M
Operating income	$70.5M
Revenue	$374.6M
Stock-based compensation	$11.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$10.68
Debt / EBITDA	0.06
Debt / equity	0.01
Debt / FCF	0.05
Long-term assets	$70.3M
Long-term liabilities	$11.8M
Net cash (debt)	$496.7M
Net cash / market cap	64.63%
Net cash growth	-1.57%
Net debt / EBITDA	-6.98
Net debt / equity	-0.79
Net debt / FCF	-6.02
Piotroski F-Score	5
Property, plant and equipment	$11.3M
Shareholders' equity	$629.1M
Tangible book value	$629.1M
Tangible book value per share	$10.68
Total assets	$720.3M
Total cash	$501.1M
Total debt	$4.5M
Total liabilities	$91.2M
WACC	15.32%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.52
Current assets	$650M
Current liabilities	$79.4M
Current ratio	8.18
Inventory turnover	1.26
Net working capital	$69.4M
Quick ratio	6.87
Working capital	$570.6M
Working capital turnover	0.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	10.73%
Dividend yield	0%
Shareholder yield	10.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$14.37
1D price change	-1.58%
1M price change	-6.21%
1M total return	-6.21%
1W price change	-5.41%
1W total return	-5.41%
1Y price change	-14.54%
1Y return CAGR	-14.55%
1Y total return	-14.54%
20-day SMA	$14.04
200-day SMA	$14.34
3M price change	-13.04%
3M total return	-13.04%
3Y price change	-30.08%
3Y return CAGR	-11.24%
3Y total return	-30.08%
50-day SMA	$14.44
50-day SMA vs 200-day SMA	50over200
52-week high	$16.67
52-week high date	2026-02-02
52-week low	$12.72
52-week low date	2026-03-12
5Y price change	-83.85%
5Y return CAGR	-30.56%
5Y total return	-83.85%
6M price change	-6.53%
6M total return	-6.53%
All-time high	$99.27
All-time high date	2021-11-02
All-time low	$6.53
All-time low date	2019-08-08
Average true range (ATR)	$0.20
Average volume	476.5K
Beta (1Y)	0.49
Beta (2Y)	0.85
Beta (5Y)	2.03
Change from 52-week high	-19.83%
Change from 52-week low	5.07%
Change from all-time high	-86.53%
Change from all-time low	104.82%
Change from open	-1.22%
Day's gap	-0.37%
Dollar volume	$6M
High price	$13.53
Low price	$13.32
Monthly RSI	39.76
Open price	$13.53
Position in 52-week range	21.43%
Premarket change	0%
Premarket close	$13.58
Premarket price	$13.58
Previous close	$13.58
Price vs 150-day SMA	-6.94%
Price vs 20-day SMA	-4.76%
Price vs 200-day SMA	-6.7%
Price vs 50-day SMA	-7.38%
Relative volume	0.95
Return from IPO open	98.07%
Return from IPO price	-4.5%
RSI	21.9
Sharpe ratio	-0.51
Sharpe ratio (3Y)	-0.24
Sharpe ratio (5Y)	-0.58
Sortino ratio	-0.58
Sortino ratio (3Y)	-0.19
Sortino ratio (5Y)	-0.69
Volume	452.6K
Weekly RSI	35.65
YTD price change	-8.95%
YTD total return	-8.95%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	47.9M
Float percentage	83.39%
Shares change (QoQ)	-7.14%
Shares change (YoY)	-10.73%
Shares held by insiders	13.21%
Shares held by institutions	53.81%
Shares outstanding	57.5M
Short % of float	4.7%
Short % of shares	3.92%
Short ratio	4.4 days

Deeper analysis on INMD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this INMD report

Is a complete INMD research report available?

No complete published report is available for InMode Ltd. (INMD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

InMode Ltd. (INMD)

Price

Financial snapshot

Fair-value bridge

Latest news · INMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on INMD

Frequently asked questions